About Us Locations Disclaimer

Dr. R. deGoma

Home
Prevention 2011
Who Needs Prevention
Benefits of Prevention
Risk Assessment
Advanced Lipid Therapy
Stent vs Medical Therapy
Specialized Center
Performance Data
Employer Mandate
Employee Prevention
Patient Mentoring
Coronary Calcium Score
Women & Heart Disease
NJPreventiveCardiology.com

 

Click here for NJ Preventive Cardiology practice brochure

 

Mentoring Program

The Million Hearts Initiative

For Physicians:

Practical Tips for Clinicians

For Communities:

Heart2Heart Talk

For Employers and Employees: You and Health Reform

     

 

 

If you are one of the more than 40 million Americans at high risk as shown above, you are eligible of optimal evidence-based heart attack and stroke prevention.

Does one have to have symptoms of the disease to seek treatment? The answer is NO. Ideally, preventive treatment should start before symptoms appear.   

If you have any one of these diagnosis, your risk for heart attack, stroke or cardiac death in the next 10 years is greater than 1 in 5. If the risk for need for stent, heart bypass surgery, angina, TIA, etc. are included, the risk is even higher.

Previous heart attack, stent, heart bypass and angina

Previous stroke, TIA, claudication, carotid or leg artery bypass or stent

Diabetes

Framingham risk score greater than 20%

Reynolds score over 20%

Framingham risk score between 6% to 20%, plus high coronary calcium score by high speed cardiac CT, or high hs-CRP, or abnormal carotid IMT, or reduced ABI.

 


Not all risk factors are created equal and not all patients require the same intensity of treatment - some patients may not need drug therapy in addition to healthier diet and positive lifestyle changes. While some risk factors are not modifiable, optimal treatment of modifiable risk factors can negate their adverse impact on cardiovascular health.

 

Our approach is personalized and our evidence-based treatment is customized to each individual patient to obtain the maximum benefits with the least possible side effects. We closely monitor response to therapy to achieve the best possible clinical outcomes.

Emil M. deGoma, MD, FACC

Medical Director,

UPenn Preventive Cardiovascular  Program

Health Premium Discount

Lower your risk for heart attack and stroke using evidence-based therapies and become eligible for a substantial premium discount by 2014.
Health Reform 2010
Prevention and Wellness Summary Provisions
Relay Health
Contact Office for Non-Urgent Matters

 

We Support Million Hearts Initiative

 

497,470 Preventable CHD Deaths Annually with Evidence-based Medical Therapy

 

JAMA: 38% of Nonacute Stents Called into Question

 

Optimal Medical Therapy Still Underused in CHD

 

Legacy Effects of Statin Therapy - Reduction in All-Cause Mortality

 

SG2 Expert Talks About Resetting Priorities in Cardiology

 

AHA: Get With The Guidelines - Not Much Improvement

 

AIM-HIGH Trial - Take Home Message

    
www.deGomaMD.com
Copyright 2001-2011     Preventing Most Heart Attacks and Strokes since 2001     eMedical Consulting     All rights reserved